Excedrin Tablet, Film Coated
NDC Package 85237-1871-2
Package Information
Excedrin (acetaminophen, aspirin, and caffeine) tablets is a medication a combination of aspirin, acetaminophen, and caffeine. This formulation utilizes a tablet, film coated delivery system. Marketed by Select Consumer Group, this product is identified by NDC 85237-1871 and is authorized under FDA application NDA020802.
Identification & Billing
- RxCUI: 209468 - EXCEDRIN 250 MG / 250 MG / 65 MG Oral Tablet
- RxCUI: 209468 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin]
- RxCUI: 209468 - APAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Excedrin]
- RxCUI: 209468 - Excedrin Extra Strength (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet
- RxCUI: 209468 - Excedrin Menstrual Complete (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet
Clinical Specifications
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
- Central Nervous System Stimulation - [PE] (Physiologic Effect)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Methylxanthine - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Xanthines - [CS]
Regulatory & Marketing
Hierarchy Structure
- 85237 - Select Consumer Group
- 85237-1871 - Excedrin
- 85237-1871-2 - 2 POUCH in 1 BLISTER PACK / 2 TABLET, FILM COATED in 1 POUCH
- 85237-1871 - Excedrin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (85237-1871). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85237-1871-2 identifies a specific commercial package of 2 pouch in 1 blister pack / 2 tablet, film coated in 1 pouch of Excedrin Migraine, a human over the counter drug labeled by Select Consumer Group. This tablet, film coated is formulated for oral use and contains acetaminophen; aspirin; caffeine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Select Consumer Group on September 30, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product is a combination of aspirin, acetaminophen, and caffeine. It is used for the temporary relief of pain from conditions such as muscle aches, toothaches, menstrual cramps, or headaches (including migraine). Aspirin and acetaminophen relieve pain by keeping your body from making certain natural substances. Caffeine helps increase the effects of aspirin and acetaminophen.
How is this Select Consumer Group product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85237187102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
